Events

SMR 2014: Autophagy Regulators: An Emerging Target in Melanoma

During the first plenary session on the second day of the Society for Melanoma Research, 2014 International Congress in Zurich, Switzerland, November 13-16, Targeted Therapies: Genetics and Biology, several researchers presented their thoughts on where they see the future of melanoma research. Various clinical issues faced while treating melanoma patients, including the optimal combination therapies and disease resistance to therapies, were discussed. Scientists also presented data and created a case for novel drug therapies in melanoma

Read More

SMR 2014: More Details Presented on Melanoma Diagnostic Test

Much of the news at the Society for Melanoma Research, 2014 International Congress, involves breakthrough therapies for treating metastatic melanoma in its later stages. But the year has brought developments in diagnostics, too. Tools to determine which patients need aggressive treatment and which ones do not are becoming important. As awareness of melanoma grows, more patients arrive at doctors’ offices with suspicious skin marks at earlier stages.

Read More
MRV News
Melanoma News
Archive
Menu